inTEST Corporation is recommended as a Buy due to its profitable and diversified test equipment business. Despite market undervaluation and lumpy cash flows, the company's acquisitions, especially Alfamation, have diversified its revenue streams and future cash flow sources, enhancing long-term growth potential. Management's cost-cutting measures and an improving order pipeline suggest better cash flow and operational performance in 2025.